NCI's Clinical Proteomic Tumor Analysis Consortium 1st Annual Scientific Symposium

On behalf of the National Cancer Institute and the Office of Cancer Clinical Proteomics Research, you are invited to the First Annual CPTAC Scientific Symposium on Wednesday, November 13, 2013. The purpose of this symposium, which consists of plenary and poster sessions, is for investigators from CPTAC community and beyond to share and discuss novel biological discoveries, analytical methods, and translational approaches using CPTAC data. All scientists who use, or wish to use CPTAC data are welcome to participate at this free event. The symposium will be held at the Natcher Conference Facility on the main campus of the National Institutes of Health in Bethesda, Maryland.

CPTAC is a consortium of proteogenomic centers to identify and annotate biological relevance of proteins derived from cancer genomes. A unique feature of the program is the utilization of genomically characterized tumors such as those from The Cancer Genome Atlas (TCGA). Preliminary results are shedding new insights on the intricate relationships between genomic abnormalities and cancer phenotypes, essential to our ability to understand basic biological processes and determine the molecular basis of cancer.

To register for this free symposium visit: http://www.capconcorp.com/meeting/2013/CPTAC/.

Sincerely,

Henry Rodriguez, Ph.D., M.B.A.
Director
Office of Cancer Clinical Proteomics Research

For questions, please contact: cancer.proteomics@mail.nih.gov